A team of UC Davis Health researchers has shown that CD34+ stem cells can be safely administered into retinitis pigmentosa ...
The global macular degeneration treatment market is poised for significant growth, projected to expand from USD 9.1 billion ...
The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA ...
Proliferative vitreoretinopathy (PVR) is an eye condition that leads to blindness and can currently only be addressed with ...
It was a mother’s instinct and fierce determination that helped to save the sight of Melbourne schoolboy Krisshiv.
This research evaluates the effects of various gene therapy viral vectors on RPE cells to determine efficacy for therapeutic ...
ABI-110, Avirmax Biopharma's proprietary gene therapy, utilizes an engineered capsid, AAV2.N54, to efficiently deliver therapeutic transgene to the macular retina. This approach aims to provide a long ...
Francesca Simonelli Session title: Multicentric longitudinal study in Usher Syndrome IB: disease course and implication for gene therapy Session: Inherited retinal diseases treatments About the ...
AAVantgarde Bio (AAVantgarde), a clinical-stage, Italian-based international biotechnology company with two proprietary Adeno-Associated Viral (AAV) vector platforms for large gene delivery, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback